Favorable outcomes of DDX41-mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide

被引：2
|
作者：
Tiong, Ing S. [1 ,2 ,3 ]
Stevenson, William S. [4 ,5 ]
Wall, Meaghan [3 ,6 ]
Yap, Yan Zhuang [1 ]
Seymour, John F. [1 ,7 ,8 ]
Kenealy, Melita [3 ,9 ]
Blombery, Piers [1 ,7 ,8 ]
机构：
[1] Peter MacCallum Canc Ctr, 300 Grattan St, Melbourne, Vic 3000, Australia
[2] Alfred Hosp, Melbourne, Vic, Australia
[3] Monash Univ, Melbourne, Vic, Australia
[4] Royal North Shore Hosp, St Leonards, NSW, Australia
[5] Univ Sydney, Northern Clin Sch, Sydney, NSW, Australia
[6] Murdoch Childrens Res Inst, Victorian Clin Genet Serv, Melbourne, Vic, Australia
[7] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia
[8] Royal Melbourne Hosp, Melbourne, Vic, Australia
[9] Cabrini Hlth, Melbourne, Vic, Australia
来源：
EJHAEM | 2023年 / 4卷 / 04期
关键词：
RISK; DDX41;
D O I：
10.1002/jha2.767
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1212 / 1215
页数：4
相关论文
共 50 条
  • [41] NPM1-Mutated Myeloid Neoplasms Irrespective of Blast Count Are Associated With Better Outcomes With Acute Myeloid Leukemia Treatment Approach
    Kale, Brandon
    Sallman, David
    Al Ali, Najla
    Xie, Zhuoer
    Yun, Seongseok
    Kuykendall, Andrew
    Walker, Alison
    Padron, Eric
    Komrokji, Rami
    Lancet, Jeffrey
    Zhang, Ling
    Chan, Onyee
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S400 - S400
  • [42] Results of a phase II study of thalidomide and azacitidine in patients with clinically advanced myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and low blast count acute myeloid leukemia (AML)
    Kenealy, Melita
    Patton, Nigel
    Filshie, Robin
    Nicol, Andrew
    Ho, Shir-Jing
    Hertzberg, Mark
    Mills, Tony
    Prosser, Ian
    Link, Emma
    Cowan, Linda
    Zannino, Diana
    Seymour, John F.
    LEUKEMIA & LYMPHOMA, 2017, 58 (02) : 298 - 307
  • [43] INFECTIOUS COMPLICATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES/ACUTE MYELOID LEUKEMIA TREATED WITH 5-AZACITIDINE
    Ramos, S.
    Santos, M.
    Tenreiro, R.
    Pereira, M.
    Cortesao, E.
    Rito, L.
    Ribeiro, M. L.
    HAEMATOLOGICA, 2015, 100 : 474 - 475
  • [44] Selective Blast Cell Reduction in Elderly Patients with Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome Treated with Methylprednisolone
    Kei Suzuki
    Kohshi Ohishi
    Takao Sekine
    Masahiro Masuya
    Naoyuki Katayama
    International Journal of Hematology, 2007, 85 : 344 - 349
  • [45] Blast cell reduction in elderly patients with acute myeloid leukemia secondary to myelodysplastic syndrome treated with methylprednisolone.
    Suzuki, Kei
    Sekine, Takao
    Ohishi, Kohshi
    Katayama, Naoyuki
    BLOOD, 2006, 108 (11) : 294B - 294B
  • [46] Selective blast cell reduction in elderly patients with acute myeloid leukemia secondary to Myelodysplastic syndrome treated with methylprednisolone
    Suzuki, Kei
    Ohishi, Kohshi
    Sekine, Takao
    Masuya, Masahiro
    Katayama, Naoyuki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2007, 85 (04) : 344 - 349
  • [47] Unique ethnic features of DDX41 mutations in patients with idiopathic cytopenia of undetermined significance, myelodysplastic syndrome, or acute myeloid leukemia
    Choi, Eun-Ji
    Cho, Young-Uk
    Hur, Eun-Hye
    Jang, Seongsoo
    Kim, Nayoung
    Park, Han-Seung
    Lee, Jung-Hee
    Lee, Kyoo-Hyung
    Kim, Si-Hwan
    Hwang, Sang-Hyun
    Seo, Eul-Ju
    Park, Chan-Jeoung
    Lee, Je-Hwan
    HAEMATOLOGICA, 2022, 107 (02) : 510 - 518
  • [48] Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: the Azalena-Trial
    Schroeder, Thomas
    Stelljes, Matthias
    Christopeit, Maximilian
    Esseling, Eva
    Scheid, Christoph
    Mikesch, Jan-Henrik
    Rautenberg, Christina
    Jaeger, Paul
    Cadeddu, Ron-Patrick
    Drusenheimer, Nadja
    Holtick, Udo
    Klein, Stefan
    Trenschel, Rudolf
    Haas, Rainer
    Germing, Ulrich
    Kroeger, Nicolaus
    Kobbe, Guido
    HAEMATOLOGICA, 2023, 108 (11) : 3001 - 3010
  • [49] Newly Mutated Genes During Myelodysplastic Syndrome Progression or Acute Myeloid Leukemia Relapse
    Song, Jinming
    Zhang, Hailing
    Zhang, Xiaohui
    Hussaini, Mohammad
    MODERN PATHOLOGY, 2019, 32
  • [50] Newly Mutated Genes During Myelodysplastic Syndrome Progression or Acute Myeloid Leukemia Relapse
    Song, Jinming
    Zhang, Hailing
    Zhang, Xiaohui
    Hussaini, Mohammad
    LABORATORY INVESTIGATION, 2019, 99
12345